Ontology highlight
ABSTRACT: Background
Necrotizing meningoencephalitis (NME, aka Pug dog encephalitis) is an inflammatory brain condition associated with advanced disease at initial presentation, rapid progression, and poor response to conventional immunomodulatory therapy.Hypothesis/objectives
That genetic risk for NME, defined by a common germline DNA haplotype located on chromosome 12, is associated with altered blood cytokine concentrations and leukocyte subsets in asymptomatic Pugs.Animals
Forty Pug dogs asymptomatic for NME from a hospital sample.Methods
Prospective observational cohort study, including germline genome-wide genotyping, plasma cytokine determination by multiplexed profiling, and leukocyte subset characterization by flow cytometric analysis.Results
Seven (18%) dogs were high risk, 10 (25%) medium risk, and 23 (58%) low risk for NME, giving a risk haplotype frequency of 30%. High and medium risk Pugs had significantly lower proportion of CD4+ T cells (median 22% [range, 7.3%-38%] vs 29% [range, 16%-41%], P = .03) and higher plasma IL-10 concentrations than low-risk Pugs (median 14.11 pg/mL [range, 9.66-344.19 pg/mL] vs 12.21 pg/mL [range, 2.59-18.53 pg/mL], P = .001). No other variables were significantly associated with the NME haplotype-based risk.Conclusions and clinical importance
These data suggest an immunological underpinning to NME and a biologic rationale for future clinical trials that investigate novel diagnostic, preventative, and therapeutic strategies for this disease.
SUBMITTER: Windsor R
PROVIDER: S-EPMC8692191 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
Windsor Rebecca R Stewart Samuel D SD Talboom Joshua J Lewis Candace C Naymik Marcus M Piras Ignazio S IS Keller Stefan S Borjesson Dori L DL Clark Gary G Khanna Chand C Huentelman Matthew M
Journal of veterinary internal medicine 20211023 6
<h4>Background</h4>Necrotizing meningoencephalitis (NME, aka Pug dog encephalitis) is an inflammatory brain condition associated with advanced disease at initial presentation, rapid progression, and poor response to conventional immunomodulatory therapy.<h4>Hypothesis/objectives</h4>That genetic risk for NME, defined by a common germline DNA haplotype located on chromosome 12, is associated with altered blood cytokine concentrations and leukocyte subsets in asymptomatic Pugs.<h4>Animals</h4>Fort ...[more]